{"ticker": {"uuid": "8ce0d059-e6d3-435d-8f1a-e7c2996e2c04", "symbol": "PACB", "name": "Pacific Biosciences of California", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026", "summary": "PacBio (NASDAQ: PACB) announced it will hold a quarterly conference call to discuss its second-quarter 2026 financial results on Wednesday, August 5, 2026, at 4:30 p.m. Eastern Time. The call will be webcast and accessible via the company's investor relations website. This call w", "url": "https://www.marketscreener.com/news/pacbio-to-report-second-quarter-2026-financial-results-on-august-5-2026-ce7f5ed2dd8af121", "source_name": "www.marketscreener.com", "published_at": "2026-07-15T20:12:36", "published_display": "15 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PacBio\u2019s next earnings update will stream live Aug. 5", "summary": "PacBio (NASDAQ: PACB) announced that it will host a quarterly conference call on Wednesday, August 5, 2026, at 4:30 p.m. Eastern Time, to discuss its second quarter 2026 financial results. Investors can access the live webcast or replay via PacBio's investor relations website or ", "url": "https://www.stocktitan.net/news/PACB/pac-bio-to-report-second-quarter-2026-financial-results-on-august-5-41b3vc4x48rp.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:12:36", "published_display": "15 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know", "summary": "Pacific Biosciences of California (PACB) shares dropped 4.49% recently, underperforming the broader market despite a 19.08% gain over the past month. The company is expected to report an EPS of -$0.14 and revenue of $42.1 million in its upcoming earnings, with analysts maintainin", "url": "https://finance.yahoo.com/markets/stocks/articles/pacific-biosciences-california-pacb-dips-221506966.html", "source_name": "Market source", "published_at": "2026-07-13T22:10:40", "published_display": "13 Jul 2026 22:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Proxy filing Summary", "summary": "This article summarizes Pacific Biosciences' (PACB) proxy filing, highlighting its focus on advancing genomics through HiFi long-read sequencing technology. The company launched two sequencers, Vega and Revio, and its proxy proposals include electing directors, ratifying auditors", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-proxy-filing_3g0nj41X", "source_name": "Quartr", "published_at": "2026-07-13T20:19:17", "published_display": "13 Jul 2026 20:19", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Short Interest & Short Float | Updated Jul 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFB5VE9yTE80ZUk5YjQ4cmdXcWxPNTRlVE51STRZbTRPenphS2x0elBLVHJLbzEyamNVUGhkTnhfQ2ZHY1ZyOTBZRHF2OFV4NEdYbTZyTEV2UExCNDIwNlRXNExodTlFd0ZZMTJSc0Fn?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific director Christopher M. Smith resigns from board", "summary": "Christopher M. Smith has resigned from the board of Pacific Biosciences of California (PACB), effective July 8, 2026. The reason for his resignation and details about a replacement were not disclosed. This information is based on an SEC 8-K filing from July 9, 2026.", "url": "https://www.tradingview.com/news/tradingview:9d63554e82d55:0-pacific-director-christopher-m-smith-resigns-from-board/", "source_name": "TradingView", "published_at": "2026-07-09T21:11:24", "published_display": "09 Jul 2026 21:11", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Reports Material Event", "summary": "Pacific Biosciences of California, Inc. (PACB) filed an 8-K report announcing the immediate resignation of board member Christopher M. Smith, effective July 8, 2026. The company stated there was no disagreement with Mr. Smith regarding its operations, policies, or practices that ", "url": "https://www.stocktitan.net/sec-filings/PACB/8-k-pacific-biosciences-of-california-inc-reports-material-event-8a1460b2b46d.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:11:24", "published_display": "09 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Goldman Sachs 46th Annual Global Healthcare Conference summary", "summary": "Pacific Biosciences (PACB) presented a summary at the Goldman Sachs 46th Annual Global Healthcare Conference, highlighting advancements in its HiFi long-read sequencing technology and the Revio platform, which has significantly reduced genome sequencing costs. The company achieve", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-goldman-sachs-46th-annual-global-healthcare-conf_3g0n07gg", "source_name": "Quartr", "published_at": "2026-07-08T20:41:17", "published_display": "08 Jul 2026 20:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Q3 2025 earnings summary", "summary": "Pacific Biosciences (PACB) reported Q3 2025 revenue of $38.4 million, driven by record consumables sales, despite a decline in instrument revenue. The company achieved a non-GAAP gross profit of $16.2 million (42% margin) and narrowed its non-GAAP net loss to $36.8 million. PACB ", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-q3-2025_3g0n0jI4", "source_name": "Quartr", "published_at": "2026-07-08T20:41:17", "published_display": "08 Jul 2026 20:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Q1 2025 earnings summary", "summary": "Pacific Biosciences (PACB) reported Q1 2025 revenue of $37.2M, a decrease from Q1 2024, despite record consumables growth, due to lower instrument sales. The company has initiated a major restructuring to focus on long-read sequencing and reduce operating expenses, lowering its f", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-q1-2025_3g0n0XKi", "source_name": "Quartr", "published_at": "2026-07-08T08:40:24", "published_display": "08 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences updates its sequencing strategy. Investors watch long-read technology", "summary": "Pacific Biosciences is refining its strategy in the genomic sequencing market by focusing on high-accuracy long-read technologies, which are gaining importance across research and clinical applications. The company generates revenue by selling instruments, consumables, and servic", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/pacific-biosciences-updates-its-sequencing-strategy-investors-watch/69715399", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T15:10:17", "published_display": "07 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQLUgtRmNzWTEzYzJoZC10dVBSUEdReURjdElHNWlfalBKX1VON1JzNm0wWjZXam5qeW1BbVU1cUZTUWxQYjNRdXJvQ21ZQWVtNlkyNFRfbXNtUG9XcmtjWG5MY092V01HVnlCOWlsQ0kycWplRlk4YW82NFU0b20tdWJ4OTFsZ1p4ZDJjVnJ5bVU1Q1c0Y1VoTXNLTTlzMGhjSFM1cjBfX1RFUQ?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Pacific Biosciences reports Q1 2026 earnings beat", "summary": "Pacific Biosciences (PACB) reported a mixed Q1 2026, beating EPS expectations with -$0.12 against a forecasted -$0.14, but missing revenue targets at $37.2 million compared to an anticipated $39.98 million. Despite flat year-over-year revenue, consumables grew by 9%, offsetting a", "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-pacific-biosciences-reports-q1-2026-earnings-beat-93CH-4670707", "source_name": "Investing.com", "published_at": "2026-07-05T21:42:27", "published_display": "05 Jul 2026 21:42", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences Q1 2026 slides: consumables hit record amid product launch", "summary": "Pacific Biosciences (NASDAQ:PACB) reported a mixed Q1 2026, beating earnings expectations but missing on revenue. The company saw record consumables revenue, driven by clinical adoption, while instrument sales declined. A significant upcoming product launch, SPRQ-Nx, is expected ", "url": "https://www.investing.com/news/company-news/pacific-biosciences-q1-2026-slides-consumables-hit-record-amid-product-launch-93CH-4670763", "source_name": "Investing.com", "published_at": "2026-07-05T18:42:27", "published_display": "05 Jul 2026 18:42", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Pacific Biosciences (PACB) The Best Rising Penny Stock?", "summary": "Pacific Biosciences of California, Inc. (PACB) has seen significant gains recently, rising over 12% in the past month and 35% since the launch of SPRQ-Nx sequencing chemistry. Wall Street analysts predict a 59% upside. The company's new chemistry reduces genome sequencing costs a", "url": "https://www.insidermonkey.com/blog/is-pacific-biosciences-pacb-the-best-rising-penny-stock-1794184/", "source_name": "Insider Monkey", "published_at": "2026-07-03T13:10:56", "published_display": "03 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why", "summary": "Pacific Biosciences of California (PACB) stock dropped 2.89% to $1.68, underperforming major market indices on a day led by gains. Despite this, the company's shares have risen 9.49% over the past month, surpassing its sector and the S&P 500. Investors are now awaiting its financ", "url": "https://finance.yahoo.com/markets/stocks/articles/pacific-biosciences-california-pacb-stock-221504374.html", "source_name": "Market source", "published_at": "2026-06-30T22:10:40", "published_display": "30 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell Small Cap Comp Growth Benchmark", "summary": "Pacific Biosciences of California, Inc. (NasdaqGS:PACB) has been added to the Russell Small Cap Comp Growth Benchmark. This addition highlights the company's position as a life science technology firm specializing in designing and manufacturing sequencing solutions, including its", "url": "https://www.marketscreener.com/news/pacific-biosciences-of-california-inc-nasdaqgs-pacb-added-to-russell-small-cap-comp-growth-benchm-ce7f5fdfdd8eff26", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T20:11:23", "published_display": "29 Jun 2026 20:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000 Growth Benchmark", "summary": "Pacific Biosciences of California, Inc. (NasdaqGS:PACB) has been added to the Russell 3000 Growth Benchmark. This news, published on June 28, 2026, marks the company's inclusion in several Russell growth indices, including the Russell Small Cap Comp Growth, Russell 2500 Growth, a", "url": "https://www.marketscreener.com/news/pacific-biosciences-of-california-inc-nasdaqgs-pacb-added-to-russell-3000-growth-benchmark-ce7f5fdfd08af224", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:39:45", "published_display": "29 Jun 2026 16:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000E Growth Benchmark", "summary": "Pacific Biosciences of California, Inc. (NasdaqGS:PACB) has been added to the Russell 3000E Growth Benchmark. The company, a life sciences technology firm, specializes in designing and manufacturing sequencing solutions, primarily known for its HiFi long-read sequencing technolog", "url": "https://www.marketscreener.com/news/pacific-biosciences-of-california-inc-nasdaqgs-pacb-added-to-russell-3000e-growth-benchmark-ce7f5fdeda89ff21", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:40:39", "published_display": "29 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Pacific Biosciences of California, Inc. \u2013 NASDAQ:PACB", "summary": "This article provides financial information for Pacific Biosciences of California, Inc. (NASDAQ: PACB), specifically focusing on its enterprise value to EBITDA forward. It indicates the stock is listed on the Nasdaq Stock Market and that the market was closed at the time the data", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T06:09:26", "published_display": "28 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Pacific Biosciences of California, Inc. \u2013 NASDAQ:PACB", "summary": "This article provides access to the \"Price to sales forward\" financial data for Pacific Biosciences of California, Inc. (NASDAQ: PACB) on the TradingView platform. It highlights that this specific financial metric is unavailable at the moment, indicating either no current data en", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:41:07", "published_display": "27 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PacBio (PACB) Stock Faces Mixed Analyst Target Changes After Valuation Revisions", "summary": "Analysts have issued mixed changes to their price targets for Pacific Biosciences of California (PACB), with some increasing targets by $0.50 and others trimming them. These adjustments reflect differing views on the company's valuation and ability to meet expectations. While the", "url": "https://uk.finance.yahoo.com/news/pacbio-pacb-stock-faces-mixed-090718948.html", "source_name": "Market source", "published_at": "2026-06-27T09:07:00", "published_display": "27 Jun 2026 09:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Pacific Biosciences of California, Inc. \u2013 NASDAQ:PACB", "summary": "This article provides a financial data point for Pacific Biosciences of California, Inc. (NASDAQ: PACB), specifically its enterprise value to EBIT forward. The content appears to be a stub or a data point from a financial platform like TradingView, indicating no further details a", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T13:10:10", "published_display": "26 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc. Actuals & Estimates (NASDAQ:PACB)", "summary": "This article provides an overview of Pacific Biosciences of California, Inc. (NASDAQ: PACB), including its current stock price, historical performance, analyst forecasts, and key financial metrics. It highlights recent stock price movements, earnings results, revenue figures, mar", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:10:10", "published_display": "26 Jun 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Pacific Biosciences of California, Inc. \u2013 FWB:P09", "summary": "This article displays the \"Enterprise value to revenue forward\" metric for Pacific Biosciences of California, Inc. (FWB:P09) on the TradingView platform. It provides financial data for the company sourced from ICE Data Services and FactSet for the Frankfurt Stock Exchange. The co", "url": "https://www.tradingview.com/symbols/FWB-P09/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T06:10:18", "published_display": "26 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Pacific Biosciences of California, Inc. \u2013 FWB:P09", "summary": "This article focuses on the enterprise value to EBIT forward metric for Pacific Biosciences of California, Inc. (FWB:P09) as displayed on the TradingView platform. It provides a snapshot of the company's financial data on the Frankfurt Stock Exchange within the Health Technology ", "url": "https://www.tradingview.com/symbols/FWB-P09/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:41:10", "published_display": "25 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PACB Stock Gains Focus As New Sequencing Tech Slashes Genome Costs", "summary": "Pacific Biosciences of California Inc. (PACB) stock has rallied due to its new SPRQ-Nx sequencing chemistry and multi-use SMRT Cells for the Revio HiFi platform, drastically cutting the cost of human genome sequencing to about $345. This innovation, coupled with improved data qua", "url": "https://stockstotrade.com/news/pacific-biosciences-of-california-inc-pacb-news-2026_06_25/", "source_name": "StocksToTrade", "published_at": "2026-06-25T17:41:10", "published_display": "25 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PACB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Pacific Biosciences of California, Inc. (PACB) stock, including analyst price targets and predictions for 2027. It details the current stock price, historical performance, market capitalization, and upcoming earnings report. The piece also inc", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/forecast-price-target/?exchange=NASDAQ", "source_name": "TradingView", "published_at": "2026-06-25T17:41:10", "published_display": "25 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Pacific Biosciences of California, Inc. (PACB) One of the Best Genomics Stocks to Buy According to Wall Street?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQWl9yMzVXb2Fia0hBYVo1VTdtakg4OTBhel91MTZua3h0aWJKRHZodnRobEdKSEFsNl82bFAwc3pJNWNuUDdnd0tuQkx0MnFKSkZtUlRidFQzZEVMYUR5T2pRazhMdnh2X3FzNFlTRHRnOVZLa1JnQzl4Q2tacklxZWxIdEktQ3ZNS0FteGN5UXUxRHoyUHFxcmppamwwbloxQmZWakZrZw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOdl90dHRUb2pFbkJLSzU5RjhvV1hka3IyNWN1OVJXX0NMMjc2d0ROY09hMllwaWIzSDBBVVhlcWc1ZUpIVVNfTHYtaldiMDgzYmJyX1lNNjhWZGhraDJobFFZZHR4S0dmcjBLOTFvdUtra3JzMURCVWF3NmhDcWQ3UkJiSGNQeTFtRTEyTVNUOVl0ejdYY0llZ2RCSDA5czQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pacific Biosciences of California, Inc. (PACB) Stock Rises on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNNUdkYzZDb2MwbjRiVHRtTlo0RE0wZ09OWW1VR1lNNmtzNk14WGp5c1JhdXFGRGVyZnJZM0FIcDVXdDlySkVLbm91UFMtU2N1NjMzZFNjRVBpV2taTVlSejBCaG52azBOem9CYU4yVzJaNVFFaEItVGp4c2FXWHdxdUdpLWRSMURuUVBWNURqMkl6Ym5zR1hJZHI4bGMtMnJaWjZBdWl0d1NMa3hFWUdmTg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPQWptQ0xrbzZEaGdRZ1packVYcU41bHFYSGh2Z0VmRDRGazlnRkRqRVFrWExIR05NTnZNVWZxa3oxUWllLWdHRXNhNS1DYzMyREtCbzU0OEM1bjFsNFF5LTJfUUpSRGl1bGRONmpsX0NKV21HeUxuZFE1eno0eERLdTQ3TzFYc2p5cE1yS0dCSmRwLWVuT09icVdxZGp4aE9RU2w0WlNoWEMzNndQdHY4anJ3?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOUGtuS1cyUFV4ei1RbFpfOWRGcF9MaHpuVXgyaXpDS2hvcWtNZWxuMmZ4SHZyb2VXODJBblprblNhQjFCQi1qajJzVmowVjBORk1yeUtndTJWNFMxTUR3QnVTdURQcjJMbkoyMFhuRmpaMk9aMFFydnlqQlBZWU4zREZOOG1CVmVsY3ROdmhUeklXU3k4SGN3TG5mbC1LOHptY0Fwc1MyU1RBUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOMGxDalNCS2pPQnVNVVdkYWlxRXppMTZuMTc3Q1FuMmpReVZ6UFVveDQ1eTJ0Y2FPajNzdFhVaGJzYWdZWUZBS2ktUmwyX0dNelRHTV9pcU9vV3V0NlpjWHQtRzJYMkQ3MEtzSjJNQ1BYel9QRHY2bGZIcHpFajdiNF9Nd1U2WHZRc2JaUnFfWkpCb1RJOFJadTUzdlVZbVhWN1hEcTk4OA?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbm9QSWEtcG9uVmV3YkNRMEJXazhMal9LcmxQVFJRMUg2TlFhakxJZ1NnaXZvcnRsLXpIQl9SWEE4UkI1c0NoZXJpNkFHMHdkM1ZUdUxyUjA4SnNSSXZrbUNBVHJ6cGhabWpnSG1TeV9jUVY5ek5xNktrWFhfZ0pFVWl0aFIwWkEtcjMwM0FTYzZqTElvZGJXM3ZTZ3ZDckJyTHpLZzg2QWE?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQWkFJcFRQWThiOFl0eDBRaFNCb3lBbDRMcWhQRzdtYm1yZ1l1WjlGZ1p0czR3MWVDUzRWeWx1Y2ZJMzVMb2VZeGZzWDBVeFpSS1BfaTJHcjNUMFA2d184b0dvaDhPRlAyMWxndUU4SURjMUEzMGNFOTBHbzcxTnA2R3JkaDhrcThyV2F2WThGMXFRaHM?oc=5", "source_name": "Market source", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026", "summary": "PacBio (NASDAQ: PACB) announced it will hold a quarterly conference call to discuss its second-quarter 2026 financial results on Wednesday, August 5, 2026, at 4:30 p.m. Eastern Time. The call will be webcast and accessible via the company's investor relations website. This call w", "url": "https://www.marketscreener.com/news/pacbio-to-report-second-quarter-2026-financial-results-on-august-5-2026-ce7f5ed2dd8af121", "source_name": "www.marketscreener.com", "published_at": "2026-07-15T20:12:36", "published_display": "15 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PacBio\u2019s next earnings update will stream live Aug. 5", "summary": "PacBio (NASDAQ: PACB) announced that it will host a quarterly conference call on Wednesday, August 5, 2026, at 4:30 p.m. Eastern Time, to discuss its second quarter 2026 financial results. Investors can access the live webcast or replay via PacBio's investor relations website or ", "url": "https://www.stocktitan.net/news/PACB/pac-bio-to-report-second-quarter-2026-financial-results-on-august-5-41b3vc4x48rp.html", "source_name": "Stock Titan", "published_at": "2026-07-15T20:12:36", "published_display": "15 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know", "summary": "Pacific Biosciences of California (PACB) shares dropped 4.49% recently, underperforming the broader market despite a 19.08% gain over the past month. The company is expected to report an EPS of -$0.14 and revenue of $42.1 million in its upcoming earnings, with analysts maintainin", "url": "https://finance.yahoo.com/markets/stocks/articles/pacific-biosciences-california-pacb-dips-221506966.html", "source_name": "Market source", "published_at": "2026-07-13T22:10:40", "published_display": "13 Jul 2026 22:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Proxy filing Summary", "summary": "This article summarizes Pacific Biosciences' (PACB) proxy filing, highlighting its focus on advancing genomics through HiFi long-read sequencing technology. The company launched two sequencers, Vega and Revio, and its proxy proposals include electing directors, ratifying auditors", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-proxy-filing_3g0nj41X", "source_name": "Quartr", "published_at": "2026-07-13T20:19:17", "published_display": "13 Jul 2026 20:19", "sentiment": "positive", "sentiment_pct": 77, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Short Interest & Short Float | Updated Jul 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTFB5VE9yTE80ZUk5YjQ4cmdXcWxPNTRlVE51STRZbTRPenphS2x0elBLVHJLbzEyamNVUGhkTnhfQ2ZHY1ZyOTBZRHF2OFV4NEdYbTZyTEV2UExCNDIwNlRXNExodTlFd0ZZMTJSc0Fn?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific director Christopher M. Smith resigns from board", "summary": "Christopher M. Smith has resigned from the board of Pacific Biosciences of California (PACB), effective July 8, 2026. The reason for his resignation and details about a replacement were not disclosed. This information is based on an SEC 8-K filing from July 9, 2026.", "url": "https://www.tradingview.com/news/tradingview:9d63554e82d55:0-pacific-director-christopher-m-smith-resigns-from-board/", "source_name": "TradingView", "published_at": "2026-07-09T21:11:24", "published_display": "09 Jul 2026 21:11", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Reports Material Event", "summary": "Pacific Biosciences of California, Inc. (PACB) filed an 8-K report announcing the immediate resignation of board member Christopher M. Smith, effective July 8, 2026. The company stated there was no disagreement with Mr. Smith regarding its operations, policies, or practices that ", "url": "https://www.stocktitan.net/sec-filings/PACB/8-k-pacific-biosciences-of-california-inc-reports-material-event-8a1460b2b46d.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:11:24", "published_display": "09 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Goldman Sachs 46th Annual Global Healthcare Conference summary", "summary": "Pacific Biosciences (PACB) presented a summary at the Goldman Sachs 46th Annual Global Healthcare Conference, highlighting advancements in its HiFi long-read sequencing technology and the Revio platform, which has significantly reduced genome sequencing costs. The company achieve", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-goldman-sachs-46th-annual-global-healthcare-conf_3g0n07gg", "source_name": "Quartr", "published_at": "2026-07-08T20:41:17", "published_display": "08 Jul 2026 20:41", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Q3 2025 earnings summary", "summary": "Pacific Biosciences (PACB) reported Q3 2025 revenue of $38.4 million, driven by record consumables sales, despite a decline in instrument revenue. The company achieved a non-GAAP gross profit of $16.2 million (42% margin) and narrowed its non-GAAP net loss to $36.8 million. PACB ", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-q3-2025_3g0n0jI4", "source_name": "Quartr", "published_at": "2026-07-08T20:41:17", "published_display": "08 Jul 2026 20:41", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences (PACB) Q1 2025 earnings summary", "summary": "Pacific Biosciences (PACB) reported Q1 2025 revenue of $37.2M, a decrease from Q1 2024, despite record consumables growth, due to lower instrument sales. The company has initiated a major restructuring to focus on long-read sequencing and reduce operating expenses, lowering its f", "url": "https://quartr.com/events/pacific-biosciences-of-california-inc-pacb-q1-2025_3g0n0XKi", "source_name": "Quartr", "published_at": "2026-07-08T08:40:24", "published_display": "08 Jul 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences updates its sequencing strategy. Investors watch long-read technology", "summary": "Pacific Biosciences is refining its strategy in the genomic sequencing market by focusing on high-accuracy long-read technologies, which are gaining importance across research and clinical applications. The company generates revenue by selling instruments, consumables, and servic", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/pacific-biosciences-updates-its-sequencing-strategy-investors-watch/69715399", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T15:10:17", "published_display": "07 Jul 2026 15:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQLUgtRmNzWTEzYzJoZC10dVBSUEdReURjdElHNWlfalBKX1VON1JzNm0wWjZXam5qeW1BbVU1cUZTUWxQYjNRdXJvQ21ZQWVtNlkyNFRfbXNtUG9XcmtjWG5MY092V01HVnlCOWlsQ0kycWplRlk4YW82NFU0b20tdWJ4OTFsZ1p4ZDJjVnJ5bVU1Q1c0Y1VoTXNLTTlzMGhjSFM1cjBfX1RFUQ?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Pacific Biosciences reports Q1 2026 earnings beat", "summary": "Pacific Biosciences (PACB) reported a mixed Q1 2026, beating EPS expectations with -$0.12 against a forecasted -$0.14, but missing revenue targets at $37.2 million compared to an anticipated $39.98 million. Despite flat year-over-year revenue, consumables grew by 9%, offsetting a", "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-pacific-biosciences-reports-q1-2026-earnings-beat-93CH-4670707", "source_name": "Investing.com", "published_at": "2026-07-05T21:42:27", "published_display": "05 Jul 2026 21:42", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences Q1 2026 slides: consumables hit record amid product launch", "summary": "Pacific Biosciences (NASDAQ:PACB) reported a mixed Q1 2026, beating earnings expectations but missing on revenue. The company saw record consumables revenue, driven by clinical adoption, while instrument sales declined. A significant upcoming product launch, SPRQ-Nx, is expected ", "url": "https://www.investing.com/news/company-news/pacific-biosciences-q1-2026-slides-consumables-hit-record-amid-product-launch-93CH-4670763", "source_name": "Investing.com", "published_at": "2026-07-05T18:42:27", "published_display": "05 Jul 2026 18:42", "sentiment": "positive", "sentiment_pct": 65, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Pacific Biosciences (PACB) The Best Rising Penny Stock?", "summary": "Pacific Biosciences of California, Inc. (PACB) has seen significant gains recently, rising over 12% in the past month and 35% since the launch of SPRQ-Nx sequencing chemistry. Wall Street analysts predict a 59% upside. The company's new chemistry reduces genome sequencing costs a", "url": "https://www.insidermonkey.com/blog/is-pacific-biosciences-pacb-the-best-rising-penny-stock-1794184/", "source_name": "Insider Monkey", "published_at": "2026-07-03T13:10:56", "published_display": "03 Jul 2026 13:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why", "summary": "Pacific Biosciences of California (PACB) stock dropped 2.89% to $1.68, underperforming major market indices on a day led by gains. Despite this, the company's shares have risen 9.49% over the past month, surpassing its sector and the S&P 500. Investors are now awaiting its financ", "url": "https://finance.yahoo.com/markets/stocks/articles/pacific-biosciences-california-pacb-stock-221504374.html", "source_name": "Market source", "published_at": "2026-06-30T22:10:40", "published_display": "30 Jun 2026 22:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell Small Cap Comp Growth Benchmark", "summary": "Pacific Biosciences of California, Inc. (NasdaqGS:PACB) has been added to the Russell Small Cap Comp Growth Benchmark. This addition highlights the company's position as a life science technology firm specializing in designing and manufacturing sequencing solutions, including its", "url": "https://www.marketscreener.com/news/pacific-biosciences-of-california-inc-nasdaqgs-pacb-added-to-russell-small-cap-comp-growth-benchm-ce7f5fdfdd8eff26", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T20:11:23", "published_display": "29 Jun 2026 20:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000 Growth Benchmark", "summary": "Pacific Biosciences of California, Inc. (NasdaqGS:PACB) has been added to the Russell 3000 Growth Benchmark. This news, published on June 28, 2026, marks the company's inclusion in several Russell growth indices, including the Russell Small Cap Comp Growth, Russell 2500 Growth, a", "url": "https://www.marketscreener.com/news/pacific-biosciences-of-california-inc-nasdaqgs-pacb-added-to-russell-3000-growth-benchmark-ce7f5fdfd08af224", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:39:45", "published_display": "29 Jun 2026 16:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc.(NasdaqGS:PACB) added to Russell 3000E Growth Benchmark", "summary": "Pacific Biosciences of California, Inc. (NasdaqGS:PACB) has been added to the Russell 3000E Growth Benchmark. The company, a life sciences technology firm, specializes in designing and manufacturing sequencing solutions, primarily known for its HiFi long-read sequencing technolog", "url": "https://www.marketscreener.com/news/pacific-biosciences-of-california-inc-nasdaqgs-pacb-added-to-russell-3000e-growth-benchmark-ce7f5fdeda89ff21", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T03:40:39", "published_display": "29 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Pacific Biosciences of California, Inc. \u2013 NASDAQ:PACB", "summary": "This article provides financial information for Pacific Biosciences of California, Inc. (NASDAQ: PACB), specifically focusing on its enterprise value to EBITDA forward. It indicates the stock is listed on the Nasdaq Stock Market and that the market was closed at the time the data", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T06:09:26", "published_display": "28 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Pacific Biosciences of California, Inc. \u2013 NASDAQ:PACB", "summary": "This article provides access to the \"Price to sales forward\" financial data for Pacific Biosciences of California, Inc. (NASDAQ: PACB) on the TradingView platform. It highlights that this specific financial metric is unavailable at the moment, indicating either no current data en", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:41:07", "published_display": "27 Jun 2026 17:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PacBio (PACB) Stock Faces Mixed Analyst Target Changes After Valuation Revisions", "summary": "Analysts have issued mixed changes to their price targets for Pacific Biosciences of California (PACB), with some increasing targets by $0.50 and others trimming them. These adjustments reflect differing views on the company's valuation and ability to meet expectations. While the", "url": "https://uk.finance.yahoo.com/news/pacbio-pacb-stock-faces-mixed-090718948.html", "source_name": "Market source", "published_at": "2026-06-27T09:07:00", "published_display": "27 Jun 2026 09:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Pacific Biosciences of California, Inc. \u2013 NASDAQ:PACB", "summary": "This article provides a financial data point for Pacific Biosciences of California, Inc. (NASDAQ: PACB), specifically its enterprise value to EBIT forward. The content appears to be a stub or a data point from a financial platform like TradingView, indicating no further details a", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T13:10:10", "published_display": "26 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc. Actuals & Estimates (NASDAQ:PACB)", "summary": "This article provides an overview of Pacific Biosciences of California, Inc. (NASDAQ: PACB), including its current stock price, historical performance, analyst forecasts, and key financial metrics. It highlights recent stock price movements, earnings results, revenue figures, mar", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:10:10", "published_display": "26 Jun 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Pacific Biosciences of California, Inc. \u2013 FWB:P09", "summary": "This article displays the \"Enterprise value to revenue forward\" metric for Pacific Biosciences of California, Inc. (FWB:P09) on the TradingView platform. It provides financial data for the company sourced from ICE Data Services and FactSet for the Frankfurt Stock Exchange. The co", "url": "https://www.tradingview.com/symbols/FWB-P09/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T06:10:18", "published_display": "26 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Pacific Biosciences of California, Inc. \u2013 FWB:P09", "summary": "This article focuses on the enterprise value to EBIT forward metric for Pacific Biosciences of California, Inc. (FWB:P09) as displayed on the TradingView platform. It provides a snapshot of the company's financial data on the Frankfurt Stock Exchange within the Health Technology ", "url": "https://www.tradingview.com/symbols/FWB-P09/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:41:10", "published_display": "25 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PACB Stock Gains Focus As New Sequencing Tech Slashes Genome Costs", "summary": "Pacific Biosciences of California Inc. (PACB) stock has rallied due to its new SPRQ-Nx sequencing chemistry and multi-use SMRT Cells for the Revio HiFi platform, drastically cutting the cost of human genome sequencing to about $345. This innovation, coupled with improved data qua", "url": "https://stockstotrade.com/news/pacific-biosciences-of-california-inc-pacb-news-2026_06_25/", "source_name": "StocksToTrade", "published_at": "2026-06-25T17:41:10", "published_display": "25 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PACB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Pacific Biosciences of California, Inc. (PACB) stock, including analyst price targets and predictions for 2027. It details the current stock price, historical performance, market capitalization, and upcoming earnings report. The piece also inc", "url": "https://www.tradingview.com/symbols/NASDAQ-PACB/forecast-price-target/?exchange=NASDAQ", "source_name": "TradingView", "published_at": "2026-06-25T17:41:10", "published_display": "25 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Pacific Biosciences of California, Inc. (PACB) One of the Best Genomics Stocks to Buy According to Wall Street?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQWl9yMzVXb2Fia0hBYVo1VTdtakg4OTBhel91MTZua3h0aWJKRHZodnRobEdKSEFsNl82bFAwc3pJNWNuUDdnd0tuQkx0MnFKSkZtUlRidFQzZEVMYUR5T2pRazhMdnh2X3FzNFlTRHRnOVZLa1JnQzl4Q2tacklxZWxIdEktQ3ZNS0FteGN5UXUxRHoyUHFxcmppamwwbloxQmZWakZrZw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: PacBio (NASDAQ:PACB) Vs The Rest Of The Life Sciences Tools & Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOdl90dHRUb2pFbkJLSzU5RjhvV1hka3IyNWN1OVJXX0NMMjc2d0ROY09hMllwaWIzSDBBVVhlcWc1ZUpIVVNfTHYtaldiMDgzYmJyX1lNNjhWZGhraDJobFFZZHR4S0dmcjBLOTFvdUtra3JzMURCVWF3NmhDcWQ3UkJiSGNQeTFtRTEyTVNUOVl0ejdYY0llZ2RCSDA5czQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California, Inc. (PACB) Stock Rises on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNNUdkYzZDb2MwbjRiVHRtTlo0RE0wZ09OWW1VR1lNNmtzNk14WGp5c1JhdXFGRGVyZnJZM0FIcDVXdDlySkVLbm91UFMtU2N1NjMzZFNjRVBpV2taTVlSejBCaG52azBOem9CYU4yVzJaNVFFaEItVGp4c2FXWHdxdUdpLWRSMURuUVBWNURqMkl6Ym5zR1hJZHI4bGMtMnJaWjZBdWl0d1NMa3hFWUdmTg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPQWptQ0xrbzZEaGdRZ1packVYcU41bHFYSGh2Z0VmRDRGazlnRkRqRVFrWExIR05NTnZNVWZxa3oxUWllLWdHRXNhNS1DYzMyREtCbzU0OEM1bjFsNFF5LTJfUUpSRGl1bGRONmpsX0NKV21HeUxuZFE1eno0eERLdTQ3TzFYc2p5cE1yS0dCSmRwLWVuT09icVdxZGp4aE9RU2w0WlNoWEMzNndQdHY4anJ3?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOUGtuS1cyUFV4ei1RbFpfOWRGcF9MaHpuVXgyaXpDS2hvcWtNZWxuMmZ4SHZyb2VXODJBblprblNhQjFCQi1qajJzVmowVjBORk1yeUtndTJWNFMxTUR3QnVTdURQcjJMbkoyMFhuRmpaMk9aMFFydnlqQlBZWU4zREZOOG1CVmVsY3ROdmhUeklXU3k4SGN3TG5mbC1LOHptY0Fwc1MyU1RBUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOMGxDalNCS2pPQnVNVVdkYWlxRXppMTZuMTc3Q1FuMmpReVZ6UFVveDQ1eTJ0Y2FPajNzdFhVaGJzYWdZWUZBS2ktUmwyX0dNelRHTV9pcU9vV3V0NlpjWHQtRzJYMkQ3MEtzSjJNQ1BYel9QRHY2bGZIcHpFajdiNF9Nd1U2WHZRc2JaUnFfWkpCb1RJOFJadTUzdlVZbVhWN1hEcTk4OA?oc=5", "source_name": "Market source", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbm9QSWEtcG9uVmV3YkNRMEJXazhMal9LcmxQVFJRMUg2TlFhakxJZ1NnaXZvcnRsLXpIQl9SWEE4UkI1c0NoZXJpNkFHMHdkM1ZUdUxyUjA4SnNSSXZrbUNBVHJ6cGhabWpnSG1TeV9jUVY5ek5xNktrWFhfZ0pFVWl0aFIwWkEtcjMwM0FTYzZqTElvZGJXM3ZTZ3ZDckJyTHpLZzg2QWE?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQWkFJcFRQWThiOFl0eDBRaFNCb3lBbDRMcWhQRzdtYm1yZ1l1WjlGZ1p0czR3MWVDUzRWeWx1Y2ZJMzVMb2VZeGZzWDBVeFpSS1BfaTJHcjNUMFA2d184b0dvaDhPRlAyMWxndUU4SURjMUEzMGNFOTBHbzcxTnA2R3JkaDhrcThyV2F2WThGMXFRaHM?oc=5", "source_name": "Market source", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 83, "total_relevant": 47, "sentiment_summary": {"positive": 14, "negative": 5, "neutral": 28, "score": 55, "total": 47, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 78, "events": [{"event": "earnings", "label": "Earnings", "weight": 12.24, "count": 25}, {"event": "general", "label": "Market update", "weight": 11.0, "count": 20}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}], "positive_events": 14, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 1.56, "latest_week": "2026-07-10", "one_week_move": -7.1, "four_week_move": 19.1, "twelve_week_move": -7.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.572416, "market_dynamics_buy_signal": false, "relative_strength": -17.571526, "fair_value_gap": -51.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.3547, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.1% over one week, +19.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 20}, {"label": "TradingView", "count": 8}, {"label": "www.marketscreener.com", "count": 4}, {"label": "Quartr", "count": 4}, {"label": "Stock Titan", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "MarketBeat", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 36}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 25}, {"label": "Market update", "count": 20}, {"label": "Analyst action", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "36", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-7.1% over one week, +19.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026"}], "updated_at": "2026-07-16T08:05:12.779943+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}